These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 16473430)
21. Buoyant sustained release granules based on chitosan. Inouye K; Machida Y; Sannan T; Nagai T Drug Des Deliv; 1989 Jan; 4(1):55-67. PubMed ID: 2775446 [TBL] [Abstract][Full Text] [Related]
22. Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo. Morgan DJ; McCormick Y; Cosolo W; Roller L; Zalcberg J Int J Clin Pharmacol Ther Toxicol; 1992 Dec; 30(12):576-81. PubMed ID: 1473873 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of an immediate release, a controlled release and a two pulse dosage form in dogs. Löbenberg R; Kim JS; Amidon GL Eur J Pharm Biopharm; 2005 May; 60(1):17-23. PubMed ID: 15848051 [TBL] [Abstract][Full Text] [Related]
24. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353 [TBL] [Abstract][Full Text] [Related]
25. Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design. Ueda S; Hata T; Asakura S; Yamaguchi H; Kotani M; Ueda Y J Drug Target; 1994; 2(1):35-44. PubMed ID: 8069582 [TBL] [Abstract][Full Text] [Related]
26. Oramucosal delivery of LHRH: pharmacokinetic studies of controlled and enhanced transmucosal permeation. Nakane S; Kakumoto M; Yukimatsu K; Chien YW Pharm Dev Technol; 1996 Oct; 1(3):251-9. PubMed ID: 9552307 [TBL] [Abstract][Full Text] [Related]
27. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets. Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223 [TBL] [Abstract][Full Text] [Related]
28. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane. Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193 [TBL] [Abstract][Full Text] [Related]
29. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride. Rajesh KS; Venkataraju MP; Gowda DV Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235 [TBL] [Abstract][Full Text] [Related]
30. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo. Quan DQ; Xu GX Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241 [TBL] [Abstract][Full Text] [Related]
31. Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices. Varma MV; Kaushal AM; Garg S J Control Release; 2005 Mar; 103(2):499-510. PubMed ID: 15763629 [TBL] [Abstract][Full Text] [Related]
32. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets. Hu LD; Liu Y; Tang X; Zhang Q Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948 [TBL] [Abstract][Full Text] [Related]
33. Simultaneous delivery of Nifedipine and Metoprolol tartarate using sandwiched osmotic pump tablet system. Kumaravelrajan R; Narayanan N; Suba V; Bhaskar K Int J Pharm; 2010 Oct; 399(1-2):60-70. PubMed ID: 20696225 [TBL] [Abstract][Full Text] [Related]
34. A new pressure-controlled colon delivery capsule for chronotherapeutic treatment of nocturnal asthma. Barakat NS; Al-Suwayeh SA; Taha EI; Bakry Yassin AE J Drug Target; 2011 Jun; 19(5):365-72. PubMed ID: 20681754 [TBL] [Abstract][Full Text] [Related]
35. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. Akhgari A; Sadeghi F; Garekani HA Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290 [TBL] [Abstract][Full Text] [Related]
36. Prilling of fatty acids as a continuous process for the development of controlled release multiparticulate dosage forms. Vervaeck A; Saerens L; De Geest BG; De Beer T; Carleer R; Adriaensens P; Remon JP; Vervaet C Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):587-96. PubMed ID: 23474381 [TBL] [Abstract][Full Text] [Related]
37. Hyaluronan-tethered opioid depots: synthetic strategies and release kinetics in vitro and in vivo. Gianolio DA; Philbrook M; Avila LZ; Young LE; Plate L; Santos MR; Bernasconi R; Liu H; Ahn S; Sun W; Jarrett PK; Miller RJ Bioconjug Chem; 2008 Sep; 19(9):1767-74. PubMed ID: 18717537 [TBL] [Abstract][Full Text] [Related]
38. Modulated release metoprolol succinate formulation based on ionic interactions: in vivo proof of concept. Ravishankar H; Patil P; Samel A; Petereit HU; Lizio R; Iyer-Chavan J J Control Release; 2006 Mar; 111(1-2):65-72. PubMed ID: 16446006 [TBL] [Abstract][Full Text] [Related]
39. Studies of chitosan/Kollicoat SR 30D film-coated tablets for colonic drug delivery. Fan LF; He W; Chang YZ; Xiang B; Du Q; Wang F; Qin M; Cao DY Int J Pharm; 2009 Jun; 375(1-2):8-15. PubMed ID: 19457627 [TBL] [Abstract][Full Text] [Related]
40. Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance. Prasad Verma PR; Chandak AR Acta Pharm; 2009 Jun; 59(2):171-86. PubMed ID: 19564142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]